Coronavirus Latest News

Omicron: Covid-19 antibody treatment ‘holds up well’ against new strain, Brii Biosciences says

The developer of China’s first approved Covid-19 antibody cocktail said lab tests had found the treatment “holds up well” against the new Omicron variant, though one of the antibodies had a “substantial drop in activity”.Brii Biosciences on Sunday also again said its therapy “retains activity” against major coronavirus strains including the highly transmissible Delta variant and its sub-lineage Delta Plus.China’s medical products regulator approved its use last Wednesday. The company said the…

Read the original article at South China Morning Post

Related Articles

Back to top button
Close